Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757.
N Engl J Med. 2023.
PMID: 37888916
Free PMC article.
Clinical Trial.
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.
Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators.
Barratt J, et al. Among authors: yureneva e.
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15.
Clin J Am Soc Nephrol. 2024.
PMID: 38214599
Clinical Trial.
Item in Clipboard
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Garcia-Pavia P, Grogan M, Kale P, Berk JL, Maurer MS, Conceição I, Di Carli M, Solomon SD, Chen C, Yureneva E, Vest J, Gillmore JD.
Garcia-Pavia P, et al. Among authors: yureneva e.
Eur J Heart Fail. 2024 Feb;26(2):397-410. doi: 10.1002/ejhf.3138. Epub 2024 Feb 6.
Eur J Heart Fail. 2024.
PMID: 38321786
Clinical Trial.
Item in Clipboard
Cite
Cite